Eurofins Scientific: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)-- Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|||
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Baber Qazi |
|
2. |
Reason for the notification |
||
a) |
Position / status |
SVP BioPharma Services Europe |
|
b) |
Initial notification / amendment |
Initial |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Eurofins Scientific S.E. |
|
b) |
LEI |
529900JEHFM47DYY3S57 |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Other |
|
Transfer of shares for nil consideration to a company wholly owned by the PDMR. No change in beneficial ownership. |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
n/a |
4,430 |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
n/a |
|
|
— Price |
n/a |
||
e) |
Date of the transaction |
2026-09-17 |
|
f) |
Place of the transaction |
XOFF |
|
For more information, please visit www.eurofins.com.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260921206488/en/
Investor Relations
Eurofins Scientific SE
Phone: +32 2 766 1620
E-mail: [email protected]
Source: Eurofins Scientific SE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primaris REIT Announces Closing of $230 Million Equity Offering
- Scale Marketing Goes All In on Growth with Veteran Enterprise Hire
- Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share